Royal Bank of Canada’s Alpha Tau Medical DRTS Stock Holding History

Royal Bank of Canada’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7K	Buy	+1,000	New	+$7.06K	﹤0.01%	6308
2024 Q4	–	Sell	-1,500	Closed	-$4K	–	6956
2024 Q3	$4K	Hold	1,500	–	–	﹤0.01%	6539
2024 Q2	$4K	Hold	1,500	–	–	﹤0.01%	6579
2024 Q1	$4K	Hold	1,500	–	–	﹤0.01%	6491
2023 Q4	$5K	Hold	1,500	–	–	﹤0.01%	6645
2023 Q3	$6K	Hold	1,500	–	–	﹤0.01%	6567
2023 Q2	$7K	Hold	1,500	–	–	﹤0.01%	6568
2023 Q1	$4K	Buy	1,500 +500	+50%	+$1.74K	﹤0.01%	6617
2022 Q4	$3K	Hold	1,000	–	–	﹤0.01%	6845
2022 Q3	$6K	Sell	1,000 -293	-23%	-$2.58K	﹤0.01%	6652
2022 Q2	$12K	Buy	+1,293	New	+$11.6K	﹤0.01%	6300

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Royal Bank of Canada's DRTS Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 1,000 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #6308 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in DRTS as recently as Q3 2024.

Royal Bank of Canada first reported a position in DRTS in Q2 2022 and has held it in 11 quarters since. The position peaked at $12K in Q2 2022. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

Royal Bank of Canada held 1,000 shares of Alpha Tau Medical worth $7K as of Q1 2026.
Alpha Tau Medical was a new Royal Bank of Canada position in Q1 2026.
Alpha Tau Medical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6308 holding.
Royal Bank of Canada first reported a position in Alpha Tau Medical in Q2 2022 and has held it in 11 quarters since.
Royal Bank of Canada's Alpha Tau Medical position peaked at $12K in Q2 2022.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.